Anthropic's upcoming IPO is already reshaping the US listing calendar. Several companies that had been preparing to go public in the coming weeks are now pushing back their debuts, hoping to avoid going head-to-head with one of the most closely watched tech offerings of the year.
Why companies are stepping aside
The reasoning is straightforward: a high-profile debut like Anthropic's tends to suck up investor attention and capital. When a major AI company hits the market, it often dominates trading volumes and media coverage, leaving less room for other newly listed stocks to get a fair look.
So instead of risking a lukewarm reception, some would-be issuers are choosing to wait. They'd rather list when the spotlight has moved on and the market has absorbed Anthropic's valuation. That's a practical decision, not a sign of weakness in the broader IPO pipeline.
The weight of a big tech valuation
This isn't just about one company's timing. The delays underscore how much influence major tech valuations now have on market dynamics. When a company of Anthropic's scale sets a price, it effectively sets a benchmark for the entire sector. Other firms in similar spaces—or even in unrelated industries—have to consider whether their own numbers will look less attractive by comparison.
That's a shift from earlier cycles, where a strong debut might lift all boats. Now, the sheer size of a leading AI player can create a gravitational pull that makes smaller offerings seem like afterthoughts. For companies that have been planning their listings for months, the calculus has changed.
What the delay means for the pipeline
The immediate effect is a quieter stretch on the US exchange calendar. But that's likely temporary. Companies that delay now are expected to reschedule once Anthropic's shares have started trading and the initial volatility settles. Bankers and lawyers are already working on revised timelines, though no specific dates have been announced.
For investors, the wait could be worth it. A less crowded market means more attention for each new listing, and potentially better pricing for companies that hold their nerve. But it also means the backlog of deals will build up, and the window after Anthropic's debut could get crowded fast.
The real test will come in the weeks after Anthropic lists. If its stock performs well, other companies may rush to follow. If it stumbles, the delays could stretch longer. Either way, the next few months will show just how much one IPO can move the market.
